View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United Kingdom |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2029-10-09 |
| Par Value | 200000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 800.00 |
| Coupon | 6.67 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 800.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Biocon Biologics Global PLC corporate note has a 6.67% fixed rate coupon paid on a semi-annual basis. It was issued on October 09, 2024 with an issue size of 800.00 million USD and matures on October 09, 2029 with a last coupon date of April 09, 2029. |
Biocon Biologics Global PLC, founded in 1978 and based in Bangalore, India, is a biopharmaceutical company dedicated to developing and providing high-quality biosimilars and biologics. The company specializes in a wide range of therapeutic areas, including oncology, diabetes, and autoimmune disorders, positioning itself as a key player in the global biopharmaceutical landscape.